Ropes & Gray advised EQRx in a strategic collaboration with Abdul Latif Jameel Health, part of the international diversified family business of Abdul Latif Jameel. The transaction was announced on November 22.
Under the agreement, Abdul Latif Jameel Health will become EQRx’s regulatory and commercial partner for two of EQRx’s oncology programs, aumolertinib and sugemalimab, in selected markets throughout the Middle East region, Turkey and all of Africa.
The Ropes & Gray team was led by life sciences partner Abigail Gregor (Boston).
Attorneys
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.